Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 2
2003 2
2012 1
2014 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Lhermitte sign after chemo-IMRT of head-and-neck cancer: incidence, doses, and potential mechanisms.
Pak D, Vineberg K, Feng F, Ten Haken RK, Eisbruch A. Pak D, et al. Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1528-33. doi: 10.1016/j.ijrobp.2011.10.052. Epub 2012 Jan 26. Int J Radiat Oncol Biol Phys. 2012. PMID: 22284690 Free PMC article.
PURPOSE: We have observed a higher rate of Lhermitte sign (LS) after chemo-intensity-modulated radiotherapy (IMRT) of head-and-neck cancer than the published rates after conventional radiotherapy. ...
PURPOSE: We have observed a higher rate of Lhermitte sign (LS) after chemo-intensity-modulated radiotherapy (IMRT) of head-and …
Multiple sclerosis: a primary care perspective.
Saguil A, Kane S, Farnell E. Saguil A, et al. Am Fam Physician. 2014 Nov 1;90(9):644-52. Am Fam Physician. 2014. PMID: 25368924 Free article.
Relapsing remitting MS is the most common type, and typical symptoms include sensory disturbances, Lhermitte sign, motor weakness, optic neuritis, impaired coordination, and fatigue. The course of disease is highly variable. The diagnosis is clinical and invo …
Relapsing remitting MS is the most common type, and typical symptoms include sensory disturbances, Lhermitte sign, motor weakn …
Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD.
Nutt JG, Burchiel KJ, Comella CL, Jankovic J, Lang AE, Laws ER Jr, Lozano AM, Penn RD, Simpson RK Jr, Stacy M, Wooten GF; ICV GDNF Study Group. Implanted intracerebroventricular. Glial cell line-derived neurotrophic factor. Nutt JG, et al. Neurology. 2003 Jan 14;60(1):69-73. doi: 10.1212/wnl.60.1.69. Neurology. 2003. PMID: 12525720 Clinical Trial.
It improved 6-OHDA- or MPTP-induced behavioral deficits in rodents and monkeys. METHODS: A multicenter, randomized, double-blind, placebo-controlled, sequential cohort study compared the effects of monthly ICV administration of placebo and 25, 75, 150, 300, and 500 to 4,00 …
It improved 6-OHDA- or MPTP-induced behavioral deficits in rodents and monkeys. METHODS: A multicenter, randomized, double-blind, pla …
Neuropathy following abuse of nitrous oxide.
Layzer RB, Fishman RA, Schafer JA. Layzer RB, et al. Neurology. 1978 May;28(5):504-6. doi: 10.1212/wnl.28.5.504. Neurology. 1978. PMID: 205816
A disabling peripheral neuropathy, mainly sensory, developed in three health workers who habitually abused nitrous oxide. The distinctive clinical picture included patterns of numbness that were radicular rather than purely distal, and a "reverse" Lhermitte sign …
A disabling peripheral neuropathy, mainly sensory, developed in three health workers who habitually abused nitrous oxide. The distinctive …
Myeloneuropathy after prolonged exposure to nitrous oxide.
Layzer RB. Layzer RB. Lancet. 1978 Dec 9;2(8102):1227-30. doi: 10.1016/s0140-6736(78)92101-3. Lancet. 1978. PMID: 82736
A neurological disorder developed after prolonged exposure to nitrous oxide in 15 patients, all but 1 of whom were dentists. 13 patients had abused nitrous oxide to some extent for periods ranging from 3 months to several years, but 2 patients were exposed to nitrous oxide only p …
A neurological disorder developed after prolonged exposure to nitrous oxide in 15 patients, all but 1 of whom were dentists. 13 patients had …